Drug Pipeline

Brivekimig Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
4
Recruiting
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-23 NCT07170917
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa		 Trial sites expanded: 69 -> 76 locations
Active Studies by Phase
Phase 2
5
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06958536 A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease Crohn's Disease Recruiting
NCT06975722 A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With… Ulcerative Colitis Recruiting
NCT07170917 Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa Hidradenitis Suppurativa Recruiting
NCT06500702 A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib… Focal Segmental Glomerulosclerosis Recruiting
NCT06812988 Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a… Type 1 Diabetes Mellitus Active, Not Recruiting
Sponsors Running Brivekimig Trials
Sanofi (5)
Disease Areas
Type 1 Diabetes (1) Diabetes (1) Crohn's Disease (1) Ulcerative Colitis (1) Hidradenitis Suppurativa (1)
Get alerts when Brivekimig trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free